VSTM (VSTM) Stock Price & Analysis
VSTM (VSTM) rose 2.76% to USD 8.2 as of September 8, 2026 at 08:17 UTC, according to Nexqual real-time market data.
VSTM last closed at USD 8.2; the session ranged USD 7.72–8.21 on volume of 2,301,509 shares. Market capitalization is —, with a 52-week range of USD 3.43–10.82 (NCM). Source: Nexqual, September 8, 2026 at 08:17 UTC.
Key Statistics (as of September 8, 2026 at 08:17 UTC)
| Price | USD 8.2 |
|---|---|
| Change | ▲ 2.76% (up) |
| Previous Close | USD 8.2 |
| Open | USD 8.2 |
| Day Range | USD 7.72 – 8.21 |
| 52-Week Range | USD 3.43 – 10.82 |
| Volume | 2,301,509 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (VSTM)
Nexqual's technical model rates VSTM "BUY" based on 5 bullish and 3 bearish signals across 128 daily candles, as of September 8, 2026 at 08:17 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 71.72 (overbought) |
| vs SMA50 | Above (USD 6.17) |
| MACD | 0.5 (positive) |
From VSTM's Latest SEC 10-K Filing (filed 2026-03-04)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | USD 1.79 | ▲ 0% |
| VTVT | vTv Therapeutics Inc. | USD 33.35 | ▼ 0.15% |
| TLPH | Talphera, Inc. | USD 1.2 | ▲ 0% |
| RIGL | Rigel Pharmaceuticals, Inc. | USD 48.67 | ▼ 1.52% |
| VTGN | VistaGen Therapeutics, Inc. | USD 0.24 | ▼ 2.88% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 08:17 UTC. This page is informational and not investment advice.